Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OPKO HEALTH, INC.

(OPK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OPKO Health, Inc.(NasdaqGS:OPK) dropped from NASDAQ Biotechnology Index

07/16/2021 | 12:00am EDT

Opko Health, Inc. has been removed from NASDAQ Biotechnology Index.


© S&P Capital IQ 2021
All news about OPKO HEALTH, INC.
09/14OPKO HEALTH : LeaderMed Form Joint Venture to Commercialize Two Drugs in Asia
MT
09/14OPKO HEALTH : LeaderMed Group and OPKO Health Form Joint Venture to Develop and ..
AQ
09/14Leadermed Group and OPKO Health Form Joint Venture to Develop and Commerciali..
CI
09/03OPKO HEALTH, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
08/30OPKO HEALTH : Completes Phase 2 COVID-19 Study Enrollment at 171 Subjects
MT
08/30OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Tr..
GL
08/30OPKO Health, Inc. Completes Enrollment in Phase 2 Trial Evaluating Rayaldee a..
CI
08/30OPKO Health to Participate in Two Upcoming Investment Conferences
GL
08/26RITE AID : Opko Health Unit Offer Free 'Back to School' COVID-19 Tests for New Y..
MT
08/26Rite Aid, in Partnership with the U.S. Department of Health and Human Service..
CI
More news
Analyst Recommendations on OPKO HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 595 M - -
Net income 2021 7,77 M - -
Net Debt 2021 - - -
P/E ratio 2021 328x
Yield 2021 -
Capitalization 2 684 M 2 684 M -
Capi. / Sales 2021 1,68x
Capi. / Sales 2022 2,27x
Nbr of Employees 5 269
Free-Float 59,5%
Chart OPKO HEALTH, INC.
Duration : Period :
OPKO Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPKO HEALTH, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 3,94 $
Average target price 6,60 $
Spread / Average Target 67,5%
EPS Revisions
Managers and Directors
Phillip Frost Chairman & Chief Executive Officer
Jon Roger Cohen Director & Senior Vice President
Adam E. Logal CFO, Treasurer, Chief Accounting Officer & SVP
Jane H. Hsaio Vice Chairman & Chief Technical Officer
Steven D. Rubin Director & Executive Vice President-Administration
Sector and Competitors
1st jan.Capi. (M$)
OPKO HEALTH, INC.-0.25%2 684
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604